ImmunoLin Receives Self-Affirmation of GRAS Status!

GRAS Status Allows Broader Use of ImmunoLin® in Food and Nutrition Products

ANKENY, IA (February 27, 2009) – Proliant Health and Biologicals is pleased to announce self-affirmed GRAS (Generally Recognized as Safe) status for the company’s proprietary, trademarked ingredient ImmunoLin® (bovine globulin concentrate). ImmunoLin is the first immunoglobulin concentrate ingredient available to the nutrition industry with GRAS status. After due consideration of the application, the FDA has no further questions regarding the safety of ImmunoLin® as an ingredient in food products. The response to the self-affirmation application for ImmunoLin is available at U.S. FDA/CFSAN: Agency Response Letter: GRAS Notice No. GRN 000255

Click PDF icon and link above to view the full press release.